Where to treat mid-term bladder cancer
summary
My mother called yesterday to say that my uncle had bladder cancer. Last year, my uncle had laser treatment for bladder stones. The effect of laser treatment is not bad. After taking a lot of drugs, he is in good health. Do you want to know where to treat mid-term bladder cancer. Is that right? Let me talk to you about where to treat mid-term bladder cancer.
Where to treat mid-term bladder cancer
Treatment 1: urachal cancer is a special type of bladder cancer. The treatment methods of urachal cancer patients include surgery, radiotherapy, chemotherapy and immunotherapy. The final treatment effect of patients with different conditions and different treatments is not the same.
Treatment 2: operation is the main treatment for urachal carcinoma, which can be divided into radical cystectomy and partial cystectomy. At present, it is advocated to use extended partial cystectomy, that is, partial cystectomy + navel resection. Because this way can minimize the pain of patients and improve the quality of life of patients. Surgical resection included the umbilicus, urachus and its surrounding tissues, tumor and bladder top, as well as removal of transverse abdominal fascia and peritoneum.
Treatment 3: with the development of minimally invasive surgery, laparoscopic surgery is also one of the choices for patients with urachal cancer, which greatly reduces the pain of patients undergoing conventional surgery. However, urachal carcinoma is characterized by local invasion, regional lymph node metastasis, lung and peritoneal metastasis, which is difficult to be detected and removed by surgery. 50% patients had local recurrence after treatment.
matters needing attention
Abnormal metabolism of tryptophan: abnormal metabolism of tryptophan can produce some metabolites, such as 3-hydroxy-2-aminoacetophenone and 3-hydroxy-o-aminobenzoic acid, which can directly affect the synthesis of RNA and DNA in cells. These metabolites are excreted into the bladder through the action of the liver, and are carcinogenic after the action of β - glucuronidase.
